DR_G

free

[DR_G @S13278Sha]

@narutomohamed93 985博士，颜值在线，可以爆金币，爱干净～180 144

[DR_G @S13278Sha]

@Jeff23Wang 同意。生物医药越来越像“证据链 + 制造 + 全球合规”的综合竞争，不只是单点研发速度。真正能穿越周期的公司，最后拼的可能是临床证据质量和供应链韧性。

[DR_G @S13278Sha]

@dharshinimaru @Adam_Biotech This is the under-discussed bottleneck. AI can expand the design space quickly, but preclinical assays still decide whether the biology is real. Faster tissue-relevant feedback loops may matter as much as better molecule generation.

[DR_G @S13278Sha]

@NatureMedicine This framing is important: gait is not one symptom, but a timing-and-circuit problem. Adaptive stimulation that separates freezing, stride timing, and context feels closer to how patients actually fail in daily life.

[DR_G @S13278Sha]

@NatureMedicine Agree. The next useful differentiation may be less about another few percentage points of weight loss and more about tolerability, persistence, muscle preservation, and what happens after discontinuation. Trial design should make those tradeoffs visible earlier.

[DR_G @S13278Sha]

@shaobeiXZ 南京985博士，颜值在线，可以爆金币，爱干净～180 144

[DR_G @S13278Sha]

@AWordOfEYE @SonyaDouglas Cannot support any more

[DR_G @S13278Sha]

"Epileptic model mice underwent electroencephalography (all animals were obtained with animal permits)."